Moreover, patients treated with SBRT have demonstrated a significant reduction in the distribution of CD8+/CD4+ T cells within the tumor as well as a substantial reduction in the number of perivascular CD8+ T cells100. The gene discussed is CD8A; the disease is neoplasm.